vulnwire
6.5med

CVE-2022-2139

Advantech iView

Published 4 y ago · modified 4 mo ago · JSON

CVSS
6.5
v3.1 · CNA
CISA KEV
No
not known exploited
EPSS
16.0%
percentile 97%
Public exploits
0
none known

The affected product is vulnerable to directory traversal, which may allow an attacker to access unauthorized files and execute arbitrary code.

CISA SSVC assessment

Exploitation
none
Automatable
no
Technical impact
partial
Assessed
18 mo ago

Exploit prediction (EPSS)

16.03% probability of exploitation in the next 30 days, higher than 97% of all scored CVEs.

CVSS scores

Assigned byVersionScoreVector
CNA3.16.5CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CNA3.16.5CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
NVD3.19.8CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected products

  • Advantech iView iView

Classification

Weakness
  • CWE-23 Relative Path Traversal
  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory

References

  • cisa.gov /uscert/ics/advisories/icsa-22-179-03 · x_refsource_MISC, x_transferred

Sources

vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.